Hercules Capital News

Hercules Capital Inc (HTGC) Q1 2024 Earnings: Aligns With Analyst EPS Projections

Yahoo Finance14minutes ago

Hercules Capital Q1 EPS $0.50, Inline, Sales $121.60M Beat $119.02M Estimate

Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.50 per share which met the analyst consensus estimate. This is a 4.17 percent increase over earnings of $0.48 per share from the same per

Benzinga17:10 ET

Express News | Hercules Capital Inc - Q1 2024 Net Investment Income "Nii" of $79.2 Mln, or $0.50 per Share

Reuters16:43 ET

Press Release: Hercules Capital Reports First Quarter 2024 Financial Results

Hercules Capital Reports First Quarter 2024 Financial Results Record Q1 2024 Total Gross Debt and Equity Commitments of $956.0 Million, an Increase of 81.7% Year-over-Year Record Q1 2024 Total Gross

Dow Jones16:06 ET

Hercules Capital To Go Ex-Dividend On May 13th, 2024 With 0.4 USD Dividend Per Share And 0.08 USD Special Dividend Per Share

May 1st - $Hercules Capital(HTGC.US)$ is trading ex-dividend on May 13th, 2024. Shareholders of record on May 14th, 2024 will receive 0.4 USD dividend per share and 0.08 USD special dividend per s

moomoo NewsApr 30 19:40 ET

Press Release: Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024

Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024 The Total Cash Distribution of $0.48 per Share for the First Quarter 2024 is Comprised of a $0.40 per

Dow JonesApr 30 06:00 ET

Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment

SynOx Therapeutics said Tuesday it signed a loan facility of up to $35 million with Hercules Capital (HTGC). The company said the initial tranche was drawn on signing, and the subsequent three tranche

MT NewswiresApr 30 05:48 ET

SynOx Therapeutics Secures up to $35m Debt Financing With Hercules Capital to Progress Development and Commercialisation of Emactuzumab

SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab for the treatment of...

PR NewswireApr 30 03:00 ET

Express News | Hercules Capital Inc. : Wells Fargo Raises Target Price to $19.5 From $18

ReutersApr 29 07:28 ET

Wells Fargo Remains a Buy on Hercules Capital (HTGC)

TipRanksApr 29 06:54 ET

Is Hercules Capital Stock a Buy?

The Motley FoolApr 27 13:18 ET

Hercules Capital (HTGC) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Yahoo FinanceApr 26 18:15 ET

Hercules Capital, Inc. (NYSE:HTGC) Looks Inexpensive But Perhaps Not Attractive Enough

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may consider Hercules Capital, Inc. (NYSE:HTGC) as an attractive investment with its 8.9

Simply Wall StApr 22 08:43 ET

Better High-Yield Buy: Hercules Capital or PennantPark?

The Motley FoolApr 20 06:30 ET

Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and

BusinesswireApr 18 06:00 ET

All You Need to Know About Hercules Capital (HTGC) Rating Upgrade to Buy

Yahoo FinanceApr 17 12:00 ET

Here Are My Top 3 Ultra-High-Yield Dividend Stocks to Buy in April

Yahoo FinanceApr 13 07:00 ET

Congresswoman Virginia Foxx Makes New Investments in Ardmore Shipping and Hercules Capital

InvestingApr 11 17:30 ET

Hercules Capital Price Target Raised to $21.00/Share From $20.00 by Piper Sandler

Hercules Capital Price Target Raised to $21.00/Share From $20.00 by Piper Sandler

Dow JonesApr 10 09:24 ET

Express News | Piper Sandler Maintains Overweight on Hercules Capital, Raises Price Target to $21

Moomoo 24/7Apr 10 09:14 ET